Search Results

The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in the Tech Loop at Research Park.

Event will feature industry leaders, cutting-edge technology in cell line development CAMBRIDGE-March 16, 2023- Sartorius, a leading international partner of life science research and the biopharmaceutical industry, will host the Sartorius Summit:

Sartorius and Repligen Corporation (NASDAQ:RGEN) today announced the launch of an integrated bioreactor system that incorporates Repligen XCell ® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified seed train and N perfusion implementation for biopharmaceutical manufacturers.

Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics.

Alpha Teknova, Inc., and Sartorius BIA Separations, which is part of the international life science group Sartorius, shared new data that demonstrates the ability to improve the recovery of full AAV capsids during anion-exchange purification, which will help gene therapy companies streamline the downstream processing workflow.

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has announced Maurice Phelan has assumed the role of President of Sartorius North America.

Following extraordinary growth in 2020 and 2021, Sartorius Stedim Biotech, a leading partner of the biopharma industry, again outperformed the market in fiscal 2022.

Following extraordinary growth in 2020 and 2021, the life science group Sartorius again outperformed the market in fiscal 2022, achieving its targets for sales revenue and profitability.

Alpha Teknova, Inc., and Sartorius BIA Separations, which is part of the international life science group Sartorius, announced that the companies have entered into a collaboration arrangement that will help gene therapy companies streamline the downstream purification process.

In a challenging market environment, the life science group Sartorius successfully placed Schuldschein loans with a volume of 650 million euros.